Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load

References

• Reyfman PA, Walter JM, Joshi N, et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199(12):1517–1536. doi:10.1164/rccm.201712-2410OC
   PubMed Web of Science ®Google Scholar
• MacParland SA, Liu JC, Ma XZ, et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun. 2018;9(1):4383. doi:10.1038/s41467-018-06318-7
   PubMed Web of Science ®Google Scholar
• Koh S, Kah J, Tham CYL, et al. Nonlytic lymphocytes engineered to express virus-specific T-cell receptors limit HBV infection by activating APOBEC3. Gastroenterology. 2018;155(1):180–193 e186. doi:10.1053/j.gastro.2018.03.027
   PubMed Web of Science ®Google Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–1555. doi:10.1016/S0140-6736(15)61412-X
   PubMed Web of Science ®Google Scholar
• Lim CJ, Lee YH, Pan L, et al. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma. Gut. 2019;68(5):916–927. doi:10.1136/gutjnl-2018-316510
   PubMed Web of Science ®Google Scholar
• Chen YY, Hao XL, Sun R, Wei HM, Tian ZG. Natural killer cell-derived interferon-gamma promotes hepatocellular carcinoma through the epithelial cell adhesion molecule-epithelial-to-mesenchymal transition axis in hepatitis B virus transgenic mice. Hepatology. 2019;69(4):1735–1750. doi:10.1002/hep.30317
   PubMed Web of Science ®Google Scholar
• Dusseaux M, Masse-Ranson G, Darche S, et al. Viral load affects the immune response to HBV in mice with humanized immune system and liver. Gastroenterology. 2017;153(6):1647. doi:10.1053/j.gastro.2017.08.034
   PubMed Web of Science ®Google Scholar
• Song J, Yang F, Wang S, et al. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis. J Viral Hepat. 2019;26(3):397–406.
   PubMed Web of Science ®Google Scholar
• Jourdain G, Ngo-Giang-Huong N, Harrison L, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N Engl J Med. 2018;378(10):911–923. doi:10.1056/NEJMoa1708131
   PubMed Web of Science ®Google Scholar
• Chen HL, Lee CN, Chang CH, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015;62(2):375–386. doi:10.1002/hep.27837
   PubMed Web of Science ®Google Scholar
• Wang M, Bian Q, Zhu Y, et al. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load. Aliment Pharmacol Ther. 2019;49(2):211–217. doi:10.1111/apt.15064
   PubMed Web of Science ®Google Scholar
• Cheung KW, Lao TT. Hepatitis B - Vertical transmission and the prevention of mother-to-child transmission. Best Pract Res Clin Obstet Gynaecol. 2020;68(78):78–88. doi:10.1016/j.bpobgyn.2020.02.014
   PubMedGoogle Scholar
• Funk AL, Lu Y, Yoshida K, et al. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):70–84. doi:10.1016/S1473-3099(20)30586-7
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086
   PubMed Web of Science ®Google Scholar
• Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324–2334. doi:10.1056/NEJMoa1508660
   PubMed Web of Science ®Google Scholar
• Boni C, Vecchi A, Rossi M, et al. TLR7 agonist increases responses of hepatitis B virus-specific T cells and natural killer cells in patients with chronic hepatitis B treated with nucleos(T)ide analogues. Gastroenterology. 2018;154(6):1764–1777 e1767. doi:10.1053/j.gastro.2018.01.030
   PubMed Web of Science ®Google Scholar
• Brown RS, McMahon BJ, Lok ASF, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology. 2016;63(1):319–333. doi:10.1002/hep.28302
   PubMed Web of Science ®Google Scholar
• Gill US, Pallett LJ, Thomas N, et al. Fine needle aspirates comprehensively sample intrahepatic immunity. Gut. 2019;68(8):1493–1503. doi:10.1136/gutjnl-2018-317071
   PubMed Web of Science ®Google Scholar
• Nayagam S, Shimakawa Y, Lemoine M. Mother-to-child transmission of hepatitis B: What more needs to be done to eliminate it around the world? J Viral Hepat. 2020;27(4):342–349. doi:10.1111/jvh.13231
   PubMed Web of Science ®Google Scholar
• Wang H, Luo H, Wan X, et al. TNF-alpha/IFN-gamma profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection. J Hepatol. 2020;72(1):45–56. doi:10.1016/j.jhep.2019.08.024
   PubMed Web of Science ®Google Scholar
• Wijaya RS, Read SA, Schibeci S, et al. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. J Hepatol. 2019;71(2):252–264. doi:10.1016/j.jhep.2019.03.012
   PubMed Web of Science ®Google Scholar
• Hoogeveen RC, Robidoux MP, Schwarz T, et al. Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection. Gut. 2019;68(5):893–904. doi:10.1136/gutjnl-2018-316644
   PubMed Web of Science ®Google Scholar
• Schuch A, Salimi Alizei E, Heim K, et al. Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load. Gut. 2019;68(5):905–915. doi:10.1136/gutjnl-2018-316641
   PubMed Web of Science ®Google Scholar
• Vandeven N, Nghiem P. Pathogen-driven cancers and emerging immune therapeutic strategies. Cancer Immunol Res. 2014;2(1):9–14. doi:10.1158/2326-6066.CIR-13-0179
   PubMed Web of Science ®Google Scholar
• Acerbi G, Montali I, Ferrigno GD, et al. Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B. J Hepatol. 2021;74(4):783–793. doi:10.1016/j.jhep.2020.10.034
   PubMed Web of Science ®Google Scholar
• Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411. doi:10.1038/nbt.4096
   PubMed Web of Science ®Google Scholar
• Haque M, Lei F, Xiong X, et al. Stem cell-derived viral antigen-specific T cells suppress HBV replication through production of IFN-gamma and TNF. iScience. 2020;23(7):101333. doi:10.1016/j.isci.2020.101333
   PubMed Web of Science ®Google Scholar
• Bertoletti A, Tan AT. HBV as a target for CAR or TCR-T cell therapy. Curr Opin Immunol. 2020;66(35):35–41. doi:10.1016/j.coi.2020.04.003
   PubMedGoogle Scholar
• Khakpoor A, Ni Y, Chen A, et al. Spatiotemporal differences in presentation of CD8 T cell epitopes during hepatitis B virus infection. J Virol. 2019;93(4). doi:10.1128/JVI.01457-18.
   PubMed Web of Science ®Google Scholar
• Rinker F, Zimmer CL, Honer Zu Siederdissen C, et al. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B. J Hepatol. 2018;69(3):584–593. doi:10.1016/j.jhep.2018.05.004
   PubMed Web of Science ®Google Scholar
• Macosko EZ, Basu A, Satija R, et al. Highly parallel genome-wide expression profiling of individual cells using Nanoliter droplets. Cell. 2015;161(5):1202–1214. doi:10.1016/j.cell.2015.05.002
   PubMed Web of Science ®Google Scholar
• Chen YP, Yin JH, Li WF, et al. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res. 2020;30(11):1024–1142.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu X, Zheng L, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564(7735):268–272. doi:10.1038/s41586-018-0694-x
   PubMed Web of Science ®Google Scholar
• Finak G, McDavid A, Yajima M, et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015;16(1):278. doi:10.1186/s13059-015-0844-5
   PubMedGoogle Scholar
• Zhu Z, Huang S, Zhang Y, et al. Bioinformatics analysis on multiple gene expression Omnibus datasets of the hepatitis B virus infection and its response to the interferon-alpha therapy. BMC Infect Dis. 2020;20(1):84. doi:10.1186/s12879-019-4720-x
   PubMed Web of Science ®Google Scholar
• Trapnell C, Cacchiarelli D, Grimsby J, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381–386. doi:10.1038/nbt.2859
   PubMed Web of Science ®Google Scholar
• Shugay M, Bagaev DV, Turchaninova MA, et al. VDJtools: unifying post-analysis of T cell receptor repertoires. PLoS Comput Biol. 2015;11(11):e1004503. doi:10.1371/journal.pcbi.1004503
   PubMed Web of Science ®Google Scholar
• Huang M, Gao Y, Yin X, et al. Characterization of T cell immunity in chronic hepatitis B virus-infected mothers with postpartum alanine transaminase flare. BMC Infect Dis. 2021;21(1):922. doi:10.1186/s12879-021-06634-2
   PubMed Web of Science ®Google Scholar
• Rice JM, Zweifach A, Lynes MA. Metallothionein regulates intracellular zinc signaling during CD4(+) T cell activation. BMC Immunol. 2016;17(1):13. doi:10.1186/s12865-016-0151-2
   PubMedGoogle Scholar
• Yurkow EJ, Makhijani PR. Flow cytometric determination of metallothionein levels in human peripheral blood lymphocytes: utility in environmental exposure assessment. J Toxicol Environ Health Part A. 1998;54(6):445–457. doi:10.1080/009841098158737
   PubMedGoogle Scholar
• Singer M, Wang C, Cong L, et al. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells. Cell. 2016;166(6):1500–1511 e1509. doi:10.1016/j.cell.2016.08.052
   PubMed Web of Science ®Google Scholar
• Read SA, O’Connor KS, Suppiah V, et al. Zinc is a potent and specific inhibitor of IFN-lambda3 signalling. Nat Commun. 2017;8(1):15245. doi:10.1038/ncomms15245
   PubMedGoogle Scholar
• Lambrechts D, Wauters E, Boeckx B, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24(8):1277–1289. doi:10.1038/s41591-018-0096-5
   PubMed Web of Science ®Google Scholar
• Orbelyan GA, Tang F, Sally B, et al. Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12. J Immunol. 2014;193(2):610–616. doi:10.4049/jimmunol.1400556
   PubMed Web of Science ®Google Scholar
• Guo C, Cai P, Jin L, et al. Single-cell profiling of the human decidual immune microenvironment in patients with recurrent pregnancy loss. Cell Discov. 2021;7(1):1. doi:10.1038/s41421-020-00236-z
   PubMed Web of Science ®Google Scholar
• Vento-Tormo R, Efremova M, Botting RA, et al. Single-cell reconstruction of the early maternal-fetal interface in humans. Nature. 2018;563(7731):347–353. doi:10.1038/s41586-018-0698-6
   PubMed Web of Science ®Google Scholar
• Kamiya T, Seow SV, Wong D, Robinson M, Campana D. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells. J Clin Invest. 2019;129(5):2094–2106. doi:10.1172/JCI123955
   PubMed Web of Science ®Google Scholar
• Mjosberg J, Svensson J, Johansson E, et al. Systemic reduction of functionally suppressive CD4(dim)CD25(high)Foxp3(+) tregs in human second trimester pregnancy is induced by progesterone and 17 beta-estradiol. J Immunol. 2009;183(1):759–769. doi:10.4049/jimmunol.0803654
   PubMed Web of Science ®Google Scholar
• Rehermann B. Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med. 2013;19(7):859–868. doi:10.1038/nm.3251
   PubMed Web of Science ®Google Scholar